SCHEMBL4699693

SCHEMBL4699693

[CH2]C(C)(CC=C(C)C)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.44
TSHR P16473 4/20 0.44
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
ESR1 P03372 3/20 0.39
ESR2 Q92731 3/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C19 P33261 1/20 0.37
HIF1A Q16665 1/20 0.37
TAAR1 Q96RJ0 1/20 0.36
ALOX15 P16050 1/20 0.36
MAPT P10636 3/20 0.36
POLB P06746 1/20 0.36
ADRB2 P07550 1/20 0.36
HTT P42858 1/20 0.36
MAPK1 P28482 1/20 0.34
ABCB11 O95342 1/20 0.33
LMNA P02545 1/20 0.33
PTGS1 P23219 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16213089 0.80 ALDH1A1 (0.46) ALDH1A1TSHRKMT2AMEN1L3MBTL1
SCHEMBL7650879 0.78 ALDH1A1 (0.45) ALDH1A1TSHRKMT2AMEN1L3MBTL1
SCHEMBL11066699 0.74 TSHR (0.49) ALDH1A1TSHRKMT2AMEN1L3MBTL1
SCHEMBL16707821 0.73 ALDH1A1 (0.41) ALDH1A1TSHRKMT2AMEN1L3MBTL1
SCHEMBL16707830 0.72 GRIN1 (0.41) ALDH1A1TSHRKMT2AMEN1L3MBTL1
SCHEMBL16213396 0.72 TAAR1 (0.44) ALDH1A1TSHRKMT2AMEN1L3MBTL1
SCHEMBL8031784 0.72 CYP2C19 (0.41) ALDH1A1TSHRKMT2AMEN1L3MBTL1
SCHEMBL7643219 0.72 CYP2C19 (0.41) ALDH1A1TSHRKMT2AMEN1L3MBTL1
SCHEMBL6086058 0.70 TAAR1 (0.44) ALDH1A1ESR1ESR2CYP3A4CYP2C19
SCHEMBL28792070 0.69 ALDH1A1 (0.41) ALDH1A1TSHRKMT2AMEN1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1051397-B1 METHOD FOR PREPARING AN N- (ALIPHATIC OR AROMATIC)CARBONYL -2-AMINOACETAMIDE COMPOUND AND A CYCLYZED COMPOUND AVENTIS PHARMA INC (US) 2008-12-31 EP disclosed
CN-1173946-C Method for preparing an N-[(aliphatic or aromatic) carbonyl]-2-aminoacetamide compound and a cyclyzed compound ���µ�˹ҩ�﹫˾ 2004-11-03 CN disclosed
EP-1212269-B1 METHODS FOR PREPARING N- (ALIPHATIC OR AROMATIC)CARBONYL)]-2-AMINOACETAMIDE COMPOUNDS AND FOR CYCLIZING SUCH COMPOUNDS AVENTIS PHARMA INC (US) 2004-10-27 EP disclosed
EP-1051397-A4 METHOD FOR PREPARING AN N- (ALIPHATIC OR AROMATIC)CARBONYL]-2-AMINOACETAMIDE COMPOUND AND A CYCLYZED COMPOUND AVENTIS PHARM PROD INC (US) 2004-09-29 EP disclosed
US-6492553-B1 A METHOD FOR PREPARING A N-((ALIPHATIC OR AROMATIC)CARBONYL) )-2-AMINOACETAMIDE COMPOUND, AND FOR PREPARING A CYCLIZED COMPOUND THEREFROM, AS WELL AS NOVEL RESIN BOUND INTERMEDIATE COMPOUNDS THAT ARE USEFUL FOR PREPARING SUCH COMPOUNDS. AVENTIS PHARAMACEUTICALS INC. 2002-12-10 US disclosed
EP-1212269-A1 METHODS FOR PREPARING N- (ALIPHATIC OR AROMATIC)CARBONYL)]-2-AMINOACETAMIDE COMPOUNDS AND FOR CYCLIZING SUCH COMPOUNDS Aventis Pharmaceuticals Products Inc. (US) 2002-06-12 EP disclosed
CN-1289324-A Method for preparing an N-[(aliphatic or aromatic) carbonyl]-2-aminoacetamide compound and a cyclyzed compound AVENTIS PHARMA INC (US) 2001-03-28 CN disclosed
WO-2001010799-A1 METHODS FOR PREPARING N-[(ALIPHATIC OR AROMATIC)CARBONYL)]-2-AMINOACETAMIDE COMPOUNDS AND FOR CYCLIZING SUCH COMPOUNDS AVENTIS PHARMACEUTICAL PRODUCTS INC. (US) 2001-02-15 WO disclosed
EP-1051397-A1 METHOD FOR PREPARING AN N- (ALIPHATIC OR AROMATIC)CARBONYL]-2-AMINOACETAMIDE COMPOUND AND A CYCLYZED COMPOUND Aventis Pharmaceuticals Products Inc. (US) 2000-11-15 EP disclosed
WO-1999038844-A1 METHOD FOR PREPARING AN N-[(ALIPHATIC OR AROMATIC)CARBONYL]-2-AMINOACETAMIDE COMPOUND AND A CYCLYZED COMPOUND AVENTIS PHARMACEUTICALS PRODUCTS INC. (US) 1999-08-05 WO disclosed